Nanorobots inside an occluded vessel (without red blood cells). The 3D workspace uses grid textures for better depth effect.



The atherosclerotic lesion was reduced due nanorobots activation. The temperatures in the region turn in expected levels.








The development of nanorobots is an emerging field with many aspects for further investigations. Simulation is an essential tool for exploring alternatives in the organization, configuration, motion planning, and control of nanodevices exploring the human body. Basically, we may observe two distinct kind of nanorobot utilization. One is nanorobots for the surgery intervention, and the other is nanorobot to monitor patientsí body.








Occluded vessel with red blood cells and nanorobots.



Molecular identification by collision contact.







The nanorobots require specific controls, sensors and actuators, basically in accordance with each kind of biomedical application. Many of such required nanodevices are being built nowadays in different research centers around the globe, as well as the necessary control specifications.








Decreased atherosclerotic lesion.



Vessel crowded by red blood cells and nanorobots.

Nanorobots search for injury targets.







Simulation can include various levels of detail, giving a trade-off between physical accuracy and the ability to control large numbers of nanorobots over relevant time scales with reasonable computational effort. Another advantage is that simulation can be done in advance of direct experimentation. It is most efficient to develop the control technology in tandem with the fabrication technologies, so that when we are able to build these devices, we will already have a good background in how to control them.








Nanorobot detailed design overview.


Nanorobot achieves the occlusion target.







The most important synergetic gears comprising any research field could be said as: creative minds and financial resources to the necessary support on facilities for any fast development. We can observe more than ever, that today the growth in investment and interest on nanotechnology is living a great scenery. The trends show that the advances in nanobiotechnology breakthroughs are being achieved in a formidable speed. Not only governments but also private companies are putting their own thrust on nanobiotech fast development as the bridge for a new time in the human history.







Nanorobots and red blood cells near the vessel occlusion.


Nanorobots navigation in a workspace with

organ inlets and obstacles.







Altogether, make quite reasonable to say as real to expect the first biological nanorobots being fully functional in five years or less. Advances on diamondoid manufacturing has also been done most recently. We may be able to use it on manufacturing nanodevices and building nanorobots in the coming ten years. Hence, in terms of time we are really talking about a very near better future.







Nanorobot injecting nutrients in the organ inlet.


Nanorobot turns back to capture more

molecules to be assembled.























Center for Automation in Nanobiotech (CAN)

Computational Nanomechatronics Lab